✦ LIBER ✦

Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation

✍ Scribed by A. H. Filipovich; C. L. Krawczak; J. H. Kersey; P. McGlave; N. K. C. Ramsay; A. Goldman; G. Goldstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

USE OF ANTI-T-CELL MONOCLONAL ANTIBODY O

✍ Prentice, H.G.; Janossy, G.; Skeggs, D.; Blacklock, H.A.; Bradstock, K.F.; Golds 📂 Article 📅 1982 🏛 The Lancet 🌐 English ⚖ 617 KB

PRETREATMENT OF DONOR BONE MARROW WITH M

✍ Filipovich, AlexandraH.; Ramsay, NormaK.C.; Warkentin, PhyllisI.; Mcglave, Phili 📂 Article 📅 1982 🏛 The Lancet 🌐 English ⚖ 550 KB

Muromonab-CD3 (Orthoclone OKT3®), methyl

✍ Benekli, M; Hahn, T; Williams, B T; Cooper, M; Roy, H N; Wallace, P; Stewart, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Anti-mitosin antibodies in a patient wit

✍ Muro, Y; Kamimoto, T; Hagiwara, M 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

Preincubation of donor bone marrow cells

✍ Paul J. Martin; John A. Hansen; E. Donnall Thomas 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 578 KB

Tacrolimus and methotrexate for the prop

✍ Uberti, J P; Silver, S M; Adams, P T; Jacobson, P; Scalzo, A; Ratanatharathorn, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB